New executive brings over 20 years of commercial life sciences experience to Cyntellect SAN DIEGO, Sept. 16
SAN DIEGO, Sept. 16 /PRNewswire/ -- Cyntellect, a privately-held life
sciences company leading the development and commercialization of live-cell
analysis and manipulation systems, announced today that it has appointed David
Burns as the Company's Vice President Sales & Marketing and Chief Operating
Officer. David will be responsible for the commercialization of Cyntellect's
products and services in the life sciences research market. He joins
Cyntellect with an extensive commercial background at leading life sciences
companies including GE Healthcare Life Sciences, Amersham and Packard
Bioscience.
"David's proven expertise in developing and commercializing system
solutions in the life sciences research market, particularly in the cellular
bioassay and analysis markets, will accelerate the successful development of
Cyntellect's commercial organization and provide us with invaluable strategic
leadership as we establish our brand and bring important, high value solutions
to life sciences researchers around the world," said Fred Koller, Ph.D.,
Cyntellect's President and Chief Executive Officer. "We are pleased and proud
to have someone of David's caliber, experience, integrity and customer-focused
nature join the Cyntellect executive team."
David comes to Cyntellect from GE Healthcare Life Sciences (formerly
Amersham Biosciences) where he filled the roles of Head of Strategic Growth,
Head of Strategic Business Development and VP Commercial Alliances. Prior to
that, he was CEO of Imaging Research Inc. in St. Catharine's, Ontario which
was acquired by Amersham in July of 2003. David joined Imaging Research and
the Amersham group from a role as Vice-President Business Development and
Marketing at Packard-BioSignal Inc., a Packard BioScience subsidiary in
Montreal, Quebec. David's prior experience included other executive business
development and marketing positions with Packard Bioscience in the USA and
Netherlands and in scientific sales with Pharmacia/LKB in the UK. David
graduated in Medical Laboratory Sciences from Napier University, Edinburgh.
About Cyntellect
Cyntellect, Inc. is a life sciences company committed to revolutionizing
the use of living cells in life science research and cellular therapy. The
Company combines expertise in high-speed cell imaging and laser-based
manipulation to develop products that enable novel cell imaging, purification,
and transfection capabilities to enhance the productivity of laboratory
research, recombinant protein production, high-content cellular assays,
functional genomics and proteomics, and cell purification, including
processing of cells for therapeutic transplantation. For additional
information please visit the Company's web site at http://www.cyntellect.com.
SOURCE Cyntellect, Inc.
